11-56642193-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002925.1(OR5AP2):c.247G>A(p.Val83Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002925.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5AP2 | NM_001002925.1 | c.247G>A | p.Val83Ile | missense_variant | 1/1 | ENST00000544374.3 | NP_001002925.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5AP2 | ENST00000544374.3 | c.247G>A | p.Val83Ile | missense_variant | 1/1 | 6 | NM_001002925.1 | ENSP00000442701.2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000509 AC: 128AN: 251420Hom.: 0 AF XY: 0.000574 AC XY: 78AN XY: 135890
GnomAD4 exome AF: 0.000223 AC: 326AN: 1461876Hom.: 0 Cov.: 33 AF XY: 0.000239 AC XY: 174AN XY: 727246
GnomAD4 genome AF: 0.000237 AC: 36AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2023 | The c.247G>A (p.V83I) alteration is located in exon 1 (coding exon 1) of the OR5AP2 gene. This alteration results from a G to A substitution at nucleotide position 247, causing the valine (V) at amino acid position 83 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at